'Caution needed' on hospital visits for patients with blood-borne viruses during pandemic

ASHM taskforce offers advice on keeping at-risk patients safe

Initiation of direct-acting antivirals (DAAs) for hepatitis C can be deferred in people with pre-cirrhosis stages of liver disease if services are stretched during the COVID-19 pandemic, new guidance suggests.